Monica Shaw MD
Chief, Division of General Internal Medicine, Palliative Medicine and Medical Education at University of L
Join to View Full Profile
201 Abraham Flexner WayLouisville, KY 40202
Phone+1 502-589-6788
Fax+1 502-587-4146
Dr. Shaw is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Louisville School of MedicineResidency, Internal Medicine, 1992 - 1995- University of Louisville School of MedicineClass of 1992
Certifications & Licensure
KY State Medical License 1993 - 2026
Publications & Presentations
PubMed
- 2 citationsThe Interprofessional Education Exchange: The Impact of a Faculty Development Program in Interprofessional Palliative Oncology Education on Trainee Competencies, Skill...Tara Schapmire, Barbara Head, Christian Davis Furman, Carol Jones, Bonika Peters
Palliative Medicine Reports. 2021-10-01 - 2 citations“Opening eyes to real interprofessional education”: results of a national faculty development initiative focused on interprofessional education in oncology palliative ...Barbara Head, Tara Schapmire, Carol Jones, Bonika Peters, Christian Davis Furman
Journal of Interprofessional Care. 2021-08-26 - 5 citationsTeaching Medical Students to Help Patients Manage Their Weight: Outcomes of an Eight-School Randomized Controlled TrialJudith K. Ockene, Lori Pbert, Sybil L. Crawford, Christine F. Frisard, Jyothi A. Pendharkar
Journal of General Internal Medicine. 2021-04-09
Press Mentions
Bristol Myers Squibb’s Abecma (Idecabtagene Vicleucel) Becomes First CAR T Cell Therapy Approved in the European Union in Earlier Lines for Triple-Class Exposed Relapsed and Refractory Multiple MyelomaMarch 21st, 2024- European Commission Expands Approval of Bristol Myers Squibb’s Reblozyl® (Luspatercept) to Include First-Line Treatment of Transfusion-Dependent Anemia in Adults with Lower-Risk Myelodysplastic Syndromes (LR-MDS)April 3rd, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
